Pages

Saturday, 22 April 2023

GlaxoSmithKline is spending 1.6 billion pounds to buy Canadian drug maker Bellus Health

GSK’s move is the largest since the Brentford based company demerged its consumer health business.

The purchase means the acquisition of Camlipixant, a drug for chronic coughs.

Meanwhile hundreds of staff at the company are due to take strike action in a dispute over pay.

Unite the Union says its members will walk out on various days in May at six sites across England and Wales.